TAMOXIFEN MARKET ANALYSIS

Tamoxifen Market, by Dosage Form (Powder, Capsule, Oral Solution, and Tablets), by Indication (Breast Cancer and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Oct 2024
Code : CMI1801
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Tamoxifen Market – Competitive Landscape

Key players operating in the global tamoxifen market include Teva Pharmaceutical Industries Ltd, AstraZeneca plc, Aegis pharmaceuticals, Watson laboratories, Inc., Allergan plc, Mylan N.V., and Apotex Inc. Market players are focusing on adopting strategies such as acquisition and mergers to provide advanced research products to sustain their presence in the market. For instance, 2018 Dare Bioscience Inc. announced merger with Pear Tree Pharmaceuticals to procure rights to develop PT-101, as a potential treatment for vaginal and vulvar atrophy for patients suffering from hormone-receptive positive breast cancer. PT-101 is a proprietary vaginal formulation being developed by Pear Tree Pharmaceuticals.